Valuation: West Pharmaceutical Services, Inc.

Market Cap 27.63B 25.17B 23.19B 21.1B 39.58B 2,559B 41.59B 282B 112B 1,398B 104B 101B 4,386B P/E 2026 *
42.5x
P/E 2027 * 38.2x
Enterprise Value 27.14B 24.71B 22.77B 20.72B 38.86B 2,513B 40.84B 277B 110B 1,372B 102B 99.66B 4,307B EV / Sales 2026 *
7.93x
EV / Sales 2027 * 7.4x
Free-Float
92.02%
Yield 2026 *
0.24%
Yield 2027 * 0.26%
1 day-1.25%
1 week-6.02%
Current month-5.15%
1 month+0.67%
3 months+10.63%
6 months+28.11%
Current year+42.24%
1 week 387.71
Extreme 387.71
420.66
1 month 381.98
Extreme 381.98
438.27
Current year 223.83
Extreme 223.83
438.27
1 year 223.83
Extreme 223.83
438.27
3 years 187.43
Extreme 187.43
438.27
5 years 187.43
Extreme 187.43
475
10 years 77.97
Extreme 77.97
475.35
Manager TitleAgeSince
Chief Executive Officer 52 2026-08-30
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Other

Director

44 0.0001%
9/15/26 Exercice

Head of Human Resources

7,572 0.0108%
9/8/26 Free

Chief Executive Officer

51,798 0.0736%
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%-6.02%+51.83%+12.13% 27.63B
+0.24%-3.88%-15.86%+3.07% 180B
+0.63%-1.36%+2.12%+34.99% 123B
+0.38%+1.74%-12.61%+8.89% 119B
-1.24%-4.25%-43.89%-1.12% 89.18B
+0.67%-4.16%-4.97%+75.60% 65.12B
+0.89%-1.33%+13.47%-7.94% 57.93B
-0.96%-2.72%-0.62%+44.86% 54.33B
-2.91%-5.00%+0.37%+35.13% 48.88B
-1.64%+1.50%+2.30%-1.14% 36.07B
Average -0.48%-0.88%-0.79%+20.45% 80B
Weighted average by Cap. -0.17%-1.17%-7.55%+18.39%

Financials

2026 *2027 *
Net sales 3.42B 3.12B 2.87B 2.61B 4.9B 317B 5.15B 34.94B 13.89B 173B 12.83B 12.56B 543B 3.62B 3.3B 3.04B 2.77B 5.19B 335B 5.45B 37B 14.71B 183B 13.59B 13.31B 575B
Net income 666M 607M 559M 509M 954M 61.69B 1B 6.8B 2.7B 33.7B 2.5B 2.45B 106B 735M 670M 617M 561M 1.05B 68.1B 1.11B 7.51B 2.99B 37.19B 2.76B 2.7B 117B
Net Debt -499M -454M -419M -381M -714M -46.18B -751M -5.09B -2.02B -25.23B -1.87B -1.83B -79.17B -836M -761M -701M -638M -1.2B -77.39B -1.26B -8.54B -3.39B -42.27B -3.14B -3.07B -133B
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Date Price Change Volume
26-11-20 $391.43 -1.33% 171,213
26-11-19 $396.69 -1.81% 819,624
26-11-18 $404.02 -2.44% 595,823
26-11-17 $414.12 -0.88% 494,112
26-11-16 $417.80 +0.33% 526,156
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
396.69USD
Average target price
471.00USD
Spread / Average Target
+18.73%